Endo International | ENDP - أصول متداولة



أصول متداولة تغيير تاريخ
AbbVie USD 29.06B 523M 2025-12
Amarin USD 628.33M 21.52M 2025-09
ANI Pharmaceuticals USD 753.12M 54.72M 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Coherus Biosciences USD 460.96M 80.75M 2025-09
Eli Lilly USD 55.63B 6.44B 2025-12
Heron Therapeutics USD 229.4M 18.48M 2025-09
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Ligand Pharmaceuticals USD 832.27M 78.35M 2025-12
Merck USD 47.56B 10.49B 2025-09
Novartis USD 28.2B 2.26B 2025-09
Pacira USD 547.97M 14.78M 2025-12
Perrigo USD 2.8B 81.8M 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Phibro Animal Health USD 862.18M 26.39M 2025-12
Supernus Pharmaceuticals USD 644.18M 50.29M 2025-12
Takeda JPY 3.12T 195.82B 2025-12
Teva Pharmaceutical Industries USD 13.95B 1.21B 2025-12
Xeris Pharmaceuticals USD 224.02M 38.44M 2025-09
Zoetis USD 6.77B 185M 2025-12